<DOC>
	<DOCNO>NCT00803439</DOCNO>
	<brief_summary>The purpose study compare relative vasoconstrictive effect test reference Clobetasol Propionate 0.05 % Topical Foam healthy , female subject .</brief_summary>
	<brief_title>Randomized Study Compare Bioavailability Two Clobetasol Propionate 0.05 % Topical Foams</brief_title>
	<detailed_description />
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Nontobacco use female subject , 18 50 year age Demonstrated blanch response Reference Drug Body Mass Index ( BMI ) 30 less Good health determine lack clinically significant abnormality medical history clinical assessment , judge Investigator Signed date informed consent form meet criteria current FDA regulation History allergy systemic topical corticosteroid Presence skin condition coloration would interfere placement test site response assessment skin blanch Presence medical condition require regular treatment prescription drug Drug alcohol addiction require treatment past 12 month prior dose Use tobacco product 30 day prior study dose Use dermatological drug therapy flexor surface forearm within 30 day dose Receipt drug part research study within 30 day prior study dose Pregnant lactating</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Clobetasol Propionate</keyword>
</DOC>